Patents
Umbilical cord blood collection
Patent Number: 6179819Patented is a medical device that can extract cord blood out of an umbilical cord.
Inventor: Haswell, John N. (Sarasota, FL)
Assignee: Unknown Assignee(s)
Date of First Priority Issue: Friday August 30th, 1996
Method for regulating neuron development and maintenance
Patent Number: 6177402This patent teaches how to induce differentiation of neurons, as well as to enhance their survival using a variety of growth factors, including leukemia inhibitory factor.
Inventors: Bartlett, Perry (North Carlton, AU); Murphy, Mark (Fitzroy, AU)
Assignee: Amrad Corporation, Ltd. (Victoria, AU)
Date of First Priority Issue: Monday March 19th, 1990
Methods and compositions for cryopreservation of cells and tissues
Patent Number: 6176089It is not good enough to encapsulate stem cells for therapeutic use, since the stem cells will have to be transported to the hospital or institution where they are needed. This patent covers methods of cryopreserving cells that have been encapsulated so that they may be shipped to the region of need.
Inventor: Bouche, Nicola (Lausanne, CH)
Assignee: Modex Therapeutics (Lausanne, CH)
Date of First Priority Issue: Tuesday October 27th, 1998
Blood-borne mesenchymal cells
Patent Number: 6174526This patent teaches the use of circulating mesenchymal stem cells for treatment of wounds.
Inventors: Cerami, Anthony (Shelter Island, NY); Bucala, Richard J. (New York, NY)
Assignee: The Picower Institute for Medical Research (Manhaset, NY)
Date of First Priority Issue: Friday February 26th, 1993
Biomatrix for soft tissue regeneration using mesenchymal stem cells
Patent Number: 6174333This patent covers implantable agents that can be administered together with mesenchymal stem cells for the purpose of creating or repairing various tissues.
Inventors: Kadiyala, Sudhakar (Baltimore, MD); Caplan, Arnold I. (Cleveland Heights, OH); Fink, David J. (Shaker Heights, OH); Young, Randall G. (Ellicott City, MD)
Assignee: Osiris Therapeutics, Inc. (Baltimore, MD); Case Western Reserve University (Cleveland, OH)
Date of First Priority Issue: Monday June 6th, 1994
Guided development and support of hydrogel-cell compositions
Patent Number: 6171610This patent covers hydrogels that may be used in combination with stem cells for the generation of various artificial tissues.
Inventors: Vacanti, Charles A. (Uxbridge, MA); Vacanti, Joseph P. (Winchester, MA); Vacanti, Martin P. (Westborough, MA)
Assignee: University of Massachusetts (Boston, MA); The Children's Medical Center Corporation (Boston, MA)
Date of First Priority Issue: Friday April 24th, 1998
Method and device for regenerating cartilage in articulating joints
Patent Number: 6171340This patent covers a procedure for repairing articular cartilage through administration of growth factors and/or stem cells.
Inventor: McDowell, Charles L. (Richmond, VA)
Assignee: Unknown Assignee(s)
Date of First Priority Issue: Friday February 27th, 1998
Erythropoietin-mediated neurogenesis
Patent Number: 6165783EPO is used clinically for treatment of anemia and is considered generally safe. This patent teaches that administration of EPO can stimulate the differentiation of neurons. Currently this concept is being tested (at least in part) by Stem Cell Therapeutics who are conducting clinical trials using EPO together with hCG for the treatment of stroke.
Inventors: Weiss, Samuel (Calgary, CA); Sorokan, S. Todd (Victoria, CA)
Assignee: Neuro Spheres Holdings Ltd. (Calgary, CA)
Date of First Priority Issue: Friday October 24th, 1997
Methods for suppressing myeloid cells with chemokines
Patent Number: 6165459This patent teaches that administration of various chemokines, such as, for example MIP-1 alpha or IL-8, inhibits the production of myeloid stem cell derived cells such as granulocytes or monocytes.
Inventors: Broxmeyer, Hal E. (Indianapolis, IN); Cooper, Scott (Indianapolis, IN); Mantel, Charles (Indianapolis, IN); Lu, Li (Indianapolis, IN)
Assignee: Indiana University Foundation (Indianapolis, IN)
Date of First Priority Issue: Wednesday December 9th, 1992
Hepes based basal nutrient medium for the isolation and culturing of stem cells
Patent Number: 6162643This is a composition of matter patent on a tissue culture medium that is useful for the growth of various stem cells.
Inventor: Wille, Jr., John J. (Trenton, NJ)
Assignee: Hy-Gene Biomedical Corporation (Ventura, CA)
Date of First Priority Issue: Monday January 29th, 1990